Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB26FX7F6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,424
Award facts
- Contract value 100% obligated
- $3,424.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $3,424.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on October 23, 2025, for the supply of Xolair 300 mg/2 mL autoinjector vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this delivery order without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The contract carries an ultimate completion date of November 14, 2025, with performance to be executed at the company's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support Department of Defense healthcare operations globally. The parent indefinite delivery contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including biologics, branded and generic medications, and medical consumables. DMS Pharmaceutical Group's established track record supplying diverse specialized pharmaceuticals positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FX7F6?
SPE2DB26FX7F6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FX7F6 worth?
The government has obligated $3,424 on SPE2DB26FX7F6.
Is contract SPE2DB26FX7F6 an order under another contract?
Yes. SPE2DB26FX7F6 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB26FX7F6 competed?
The extent of competition for SPE2DB26FX7F6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award